ALNY vs. RTX
ALNY (Alnylam Pharmaceuticals, Inc.) and RTX (RTX Corporation) are both stocks. ALNY operates in Biotechnology (Healthcare), while RTX operates in Aerospace & Defense (Industrials). Over the past 10 years, ALNY returned 18.16%/yr vs 16.13%/yr for RTX. At a 0.28 correlation, their price movements are largely independent.
Performance
ALNY vs. RTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ALNY achieves a -27.53% return, which is significantly lower than RTX's 2.39% return. Over the past 10 years, ALNY has outperformed RTX with an annualized return of 18.16%, while RTX has yielded a comparatively lower 16.13% annualized return.
ALNY
- 1D
- 0.62%
- 1M
- -3.12%
- YTD
- -27.53%
- 6M
- -27.72%
- 1Y
- -7.97%
- 3Y*
- 14.36%
- 5Y*
- 10.66%
- 10Y*
- 18.16%
RTX
- 1D
- 2.51%
- 1M
- 5.30%
- YTD
- 2.39%
- 6M
- 1.09%
- 1Y
- 29.87%
- 3Y*
- 27.02%
- 5Y*
- 19.09%
- 10Y*
- 16.13%
ALNY vs. RTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ALNY Alnylam Pharmaceuticals, Inc. | -27.53% | 68.99% | 22.94% | -19.46% | 40.14% | 30.48% | 12.85% | 57.96% | -42.61% | 239.34% |
RTX RTX Corporation | 2.39% | 61.44% | 40.76% | -14.44% | 20.01% | 23.27% | -7.70% | 43.82% | -14.66% | 19.13% |
Correlation
The correlation between ALNY and RTX is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 2004 | 0.28 |
The correlation between ALNY and RTX shifts across timeframes, from 0.10 (1 year) to 0.28 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ALNY:
$39.83B
RTX:
$254.35B
ALNY:
$4.26
RTX:
$5.34
ALNY:
67.59
RTX:
34.93
ALNY:
9.10
RTX:
2.80
ALNY:
37.04
RTX:
3.84
ALNY:
$4.29B
RTX:
$90.37B
ALNY:
$2.51B
RTX:
$18.27B
ALNY:
$729.86M
RTX:
$13.81B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ALNY vs. RTX — Risk / Return Rank
ALNY
RTX
ALNY vs. RTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Alnylam Pharmaceuticals, Inc. (ALNY) and RTX Corporation (RTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ALNY | RTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.43 | ||
| Sortino ratioReturn per unit of downside risk | -1.91 | ||
| Omega ratioGain probability vs. loss probability | 0.99 | 1.23 | -0.24 |
| Calmar ratioReturn relative to maximum drawdown | -0.18 | 1.55 | -1.74 |
| Martin ratioReturn relative to average drawdown | -0.32 | 4.10 | -4.42 |
Loading charts...
Drawdowns
ALNY vs. RTX - Drawdown Comparison
The maximum ALNY drawdown since its inception was -83.58%, which is greater than RTX's maximum drawdown of -55.14%. Use the drawdown chart below to compare losses from any high point for ALNY and RTX.
Loading charts...
Drawdown Indicators
| ALNY | RTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.58% | -55.14% | -28.44% |
Max Drawdown (1Y)Largest decline over 1 year | -43.39% | -19.32% | -24.07% |
Max Drawdown (3Y)Largest decline over 3 years | -43.39% | -28.99% | -14.40% |
Max Drawdown (5Y)Largest decline over 5 years | -43.39% | -32.84% | -10.55% |
Max Drawdown (10Y)Largest decline over 10 years | -59.95% | -51.98% | -7.97% |
Current DrawdownCurrent decline from peak | -41.33% | -11.78% | -29.55% |
Average DrawdownAverage peak-to-trough decline | -30.61% | -13.03% | -17.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.66% | 7.32% | +17.34% |
Volatility
ALNY vs. RTX - Volatility Comparison
Alnylam Pharmaceuticals, Inc. (ALNY) and RTX Corporation (RTX) have volatilities of 9.83% and 9.72%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ALNY | RTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.83% | 9.72% | +0.11% |
Volatility (6M)Calculated over the trailing 6-month period | 25.55% | 19.09% | +6.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 37.11% | 24.66% | +12.45% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.86% | 24.05% | +24.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 53.63% | 27.83% | +25.80% |
Dividends
ALNY vs. RTX - Dividend Comparison
ALNY has not paid dividends to shareholders, while RTX's dividend yield for the trailing twelve months is around 1.49%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALNY Alnylam Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RTX RTX Corporation | 1.49% | 1.46% | 2.14% | 2.76% | 2.14% | 2.33% | 21.21% | 1.96% | 2.66% | 2.13% | 2.39% | 2.66% |
Financials
ALNY vs. RTX - Financials Comparison
This section allows you to compare key financial metrics between Alnylam Pharmaceuticals, Inc. and RTX Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ALNY vs. RTX - Profitability Comparison
ALNY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Alnylam Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 1.17B. Therefore, the gross margin over that period was 0.0%.
RTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, RTX Corporation reported a gross profit of 4.59B and revenue of 22.08B. Therefore, the gross margin over that period was 20.8%.
ALNY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Alnylam Pharmaceuticals, Inc. reported an operating income of 268.64M and revenue of 1.17B, resulting in an operating margin of 23.0%.
RTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, RTX Corporation reported an operating income of 2.56B and revenue of 22.08B, resulting in an operating margin of 11.6%.
ALNY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Alnylam Pharmaceuticals, Inc. reported a net income of 205.99M and revenue of 1.17B, resulting in a net margin of 17.7%.
RTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, RTX Corporation reported a net income of 2.06B and revenue of 22.08B, resulting in a net margin of 9.3%.
Frequently Asked Questions
ALNY and RTX have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ALNY has higher volatility (9.83%) compared to RTX (9.72%). In terms of maximum drawdown, ALNY dropped -83.58% vs RTX's -55.14%.
RTX currently has the higher Sharpe Ratio (1.22 vs -0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ALNY and RTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer